Zhao Liangxin, Qian Shensi, Wang Xu, Si Tiantian, Xu Jinke, Wang Zhengtao, Sun Qihui, Yang Yong, Rong Rong
College of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, 250355, China.
Shandong Center for Disease Control and Prevention, Jinan, 250014, Shandong, China.
J Ethnopharmacol. 2024 Jan 30;319(Pt 3):117318. doi: 10.1016/j.jep.2023.117318. Epub 2023 Oct 12.
Chaihu Guizhi decoction (CGD) is a classic Traditional Chinese Medicine (TCM) prescription for the treatment of influenza and fever, composes of Bupleuri Radix (Chaihu), Cinnamomi Ramulus (Guizhi), Scutellariae Radix (Huangqin), Codonopsis Radix (Dangshen), Glycyrrhizae Radix Et Rhizoma Praeparata Cum Melle (Zhigancao), Pinelliae Rhizoma Praeparatum (Fabanxia), Zingiberis Rhizoma Recens (Shengjiang), Paeoniae Radix Alba (Baishao) and Jujubae Fructus (Dazao) in the ratio of 12:4.5:4.5:4.5:3:6:4.5:4.5:4. The efficacy of TCM, if there are differences, depends on the different extraction methods and extracted components.
This study was to evaluate the anti-influenza virus effect of CGD extracts with different extraction methods, analyze the components and explore their correlation.
CGD were prepared with four extraction methods respectively, the traditional decoction (TD), two steps alcohol-water extraction (AWE), alcohol reflux extraction (AE) and water reflux extraction (WE). Based on the influenza mouse model, the efficacy of anti-influenza virus in vivo of the four CGD extracts were evaluated with the therapeutic index of body weight, rectal temperature, lung index, thymus index and lung viral load of mice. The chemical components in four CGD extracts, and compounds absorbed in rats blood with prototypes or metabolites were identified by UPLC-Q-Exactive/MS. The partial least squares (PLS) method was used to explore the correlation between the components variation in CGD extracts and the comprehensive efficacy index. The potential effective components were further accessed by molecular docking.
Comparing with the other three extracts, AWE has the best anti-influenza effect. It could ameliorate the symptoms caused by influenza virus infection in mice, increase body weight and rectal temperature, reduce the lung index and virus load in lung tissue. 129, 144, 140 and 129 components were identified from TD, AWE, AE, and WE respectively. The identified components were mainly including flavonoids, terpenoids, organic acids, phenylpropanoids, amino acids, nucleosides, phenols, alkaloids, etc. 43 prototypes and 49 metabolites of CGD were detected in rat plasma after oral administration. Seven components, cinnamaldehyde, wogonoside, baicalin, baicalein, gallic acid, oroxylinA-7-O-glucuronide and coumarin, showed significant correlation with anti-influenza effects, all of which had good binding activity with NA, IL-6, STAT3, AKT1, EGFR and TNF.
Two steps alcohol-water extraction was optimal for CGD preparation. Cinnamaldehyde, wogonoside, oroxylinA-7-O-glucuronide, coumarin, gallic acid, baicalein and baicalin play a certain essential role in anti-influenza effects and may be taken as a potential maker compounds for quality evaluation of CGD.
柴胡桂枝汤(CGD)是治疗流感和发热的经典中药方剂,由柴胡、桂枝、黄芩、党参、炙甘草、法半夏、生姜、白芍和大枣按12:4.5:4.5:4.5:3:6:4.5:4.5:4的比例组成。中药的疗效(若存在差异)取决于不同的提取方法和提取物成分。
本研究旨在评估不同提取方法得到的CGD提取物的抗流感病毒作用,分析其成分并探索它们之间的相关性。
分别采用四种提取方法制备CGD,即传统水煎法(TD)、两步醇水提取法(AWE)、乙醇回流提取法(AE)和水回流提取法(WE)。基于流感小鼠模型,通过小鼠体重、直肠温度、肺指数、胸腺指数和肺病毒载量的治疗指数评估四种CGD提取物在体内的抗流感病毒疗效。采用超高效液相色谱-四极杆-静电场轨道阱高分辨质谱(UPLC-Q-Exactive/MS)鉴定四种CGD提取物中的化学成分以及大鼠血液中以原型或代谢产物形式吸收的化合物。采用偏最小二乘法(PLS)探索CGD提取物中成分变化与综合疗效指标之间的相关性。通过分子对接进一步评估潜在的有效成分。
与其他三种提取物相比,AWE的抗流感效果最佳。它可以改善流感病毒感染小鼠引起的症状,增加体重和直肠温度,降低肺指数和肺组织中的病毒载量。分别从TD、AWE、AE和WE中鉴定出129、144、140和129种成分。鉴定出的成分主要包括黄酮类、萜类、有机酸、苯丙素类、氨基酸、核苷、酚类、生物碱等。口服给药后,在大鼠血浆中检测到CGD的43种原型和49种代谢产物。七种成分,即肉桂醛、汉黄芩苷、黄芩苷、黄芩素、没食子酸、木犀草素-7-O-葡萄糖醛酸苷和香豆素,与抗流感作用呈显著相关,它们与神经氨酸酶(NA)、白细胞介素-6(IL-6)、信号转导和转录激活因子3(STAT3)、蛋白激酶B(AKT1)、表皮生长因子受体(EGFR)和肿瘤坏死因子(TNF)均具有良好的结合活性。
两步醇水提取法是制备CGD的最佳方法。肉桂醛、汉黄芩苷、木犀草素-7-O-葡萄糖醛酸苷、香豆素、没食子酸、黄芩素和黄芩苷在抗流感作用中发挥一定的关键作用,可作为CGD质量评价的潜在标志性化合物。